Thomas Woiwode - May 25, 2023 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Director, 10%+ Owner
Signature
/s/ Edgar Cale, Attorney-in-Fact
Stock symbol
PASG
Transactions as of
May 25, 2023
Transactions value $
$0
Form type
4
Date filed
5/26/2023, 04:38 PM
Previous filing
Jun 27, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Director Stock Option (Right to Buy) Award $0 +24K $0.00 24K May 25, 2023 Common Stock 24K $1.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in full on the earlier of: (i) the one year anniversary of the grant date or (ii) the date of the issuer's 2024 Annual Meeting of its stockholders, subject to the reporting person's continuous service to the issuer on such date.